CopyMark Law Group
4.9/5
Drawing for STYPGEL

USPTO serial 79218792

STYPGEL

Reviewed by CopyMark Law Group

Reg. 5435696Status 709
Filing date
Status date
Registration date
Apr 3, 2018
Examiner
O'BRIEN, ELIZABETH A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with STYPGEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark Lebow

Mark Lebow Ladas & Parry1700 Diagonal RoadSuite 505Alexandria, VA 22314

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of blood disorders, infectious diseases, pain inflammation, sepsis, alopecia, obesity and cognitive disorders; styptic preparations; pharmaceutical preparations, namely, a blood clotting aid and delivery system in the nature of thrombin for human use; gelatin glue for medical purposes; collagen for medical purposes; wadding for medical purposes; absorbent wadding for dressings; absorbable hemostatics for medical purposes; surgical glues; injectable pharmaceuticals for the purpose of tissue trauma hemostasis; biological preparations for the prevention and treatment of infectious diseases, blood disorders, pain inflammation, sepsis, alopecia, obesity and cognitive disorders for veterinary purposes; surgical dressingsSECTION 71 - CANCELLED—
010Medical apparatus and instruments for introducing pharmaceutical preparations into the human body; surgical apparatus and instruments; medical devices, namely, hemostats that clamp blood vessels to diminish or halt blood flow; syringes for medical purposes; syringes for injections; catheters; injectors for medical purposes, namely, medical fluid injectors; drainage tubes for medical purposes; hypodermic syringes; instrument for hemostatic sutures, namely, suture materials; surgical implants comprised of artificial materials; implantable subcutaneous drug delivery devices sold empty; instrument for enhancing drug absorption for medical purposes, namely, medical infusion and injection devices for administering drugs; medical apparatus, namely, infusion and injection devices for delivering drugs into the human bodySECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 5, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Nov 17, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Nov 17, 2025INPCINVALIDATION PROCESSED—
Jul 11, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 18, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 18, 2024C71TCANCELLED SECTION 71—
Apr 3, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 29, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 12, 2018XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jul 12, 2018XXCRGENERIC MADRID TRANSACTION CREATED—
Jul 3, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 3, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 27, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jan 16, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 16, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 10, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 10, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 27, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 6, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 5, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Dec 5, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 5, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 5, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 30, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 29, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 29, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 25, 2017RFNTREFUSAL PROCESSED BY IB—
Nov 3, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 3, 2017RFRRREFUSAL PROCESSED BY MPU—
Oct 27, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 27, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 26, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2017DOCKASSIGNED TO EXAMINER—
Oct 23, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance